Nitrous oxide activation by a ruthenium porphyrin

DOI: 10.1021/ja00125a025

Source and publish data:

Journal of the American Chemical Society p. 5594 - 5595 (1995)

Update date:2022-07-29

Topics: Reductive Activation

Authors:

Groves, John T.

Roman, J. Scott

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00125a025

Full text of DOI:10.1021/ja00125a025

Products guided by the article

Product name:oxoruthenium(IV) tetramesitylporphyrin

Cas No:110613-27-9

R&D Labs maybe for 110613-27-9

LIDE PHARMACEUTICALS LIMITED

website:http://www.lidepharma.com

Contact:+86-25-58409506

Address:Chungking Express Nos.36 Nathan Road，Kowloon, HK
Shanghai Science Peptide Biological Technology Co.,ltd

website:http://www.scipeptide.com

Contact:+86-21-51099675

Address:No.8 Changyang Rd
NANCHANG QINZHI SCI&TEC.CO.,LTD(expird)

Contact:+86-13687004106

Address:Hero South Road,Hero Zone,Nanchang,Jiangxi,China
Improve Medical Technology(Nanxiong) Co., Ltd

Contact:86-751-3836997

Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Ningbo Hi-tech Zone Nice-Synth Chemical Industry Ltd.

Contact:+86-(574)-81110986

Address:No. 1210, Building 3, Wante Business Centre, Hi-tech Zone, Ningbo

Relevant to this article

Doi:10.1007/BF00695658
(1965)
The first synthesis of ent-agelasine F

Doi:10.1016/j.tet.2008.10.081
(2009)
Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials

Doi:10.1016/j.ejmech.2011.01.008
(2011)
Diphenyl cyancarbonimidate and dichlorodiphenoxymethane as synthons for the construction of heterocyclic systems of medicinal interest

Doi:10.1002/jhet.5570240153
(1987)
An Efficint Synthesis of 4-Aryl-1,2,3,4-terahydroisoquinolines

Doi:10.1039/c39870000191
(1987)
Doi:10.1039/jr9430000394
(1943)

Article Doi